These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 29721603)

  • 1. Pneumatosis Intestinalis Associated with the Tyrosine Kinase Inhibitor Nintedanib.
    Poor A; Braman SS
    Lung; 2018 Jun; 196(3):373-375. PubMed ID: 29721603
    [No Abstract]   [Full Text] [Related]  

  • 2. Images in emergency medicine. Elderly woman with abdominal pain. Secondary pneumatosis intestinalis.
    Augustin G
    Ann Emerg Med; 2010 Apr; 55(4):390-400. PubMed ID: 20346841
    [No Abstract]   [Full Text] [Related]  

  • 3. Delayed Presentation of Hepatocellular Liver Injury After Nintedanib Administration.
    Olin JL; Woods JA; Garner SJ
    Am J Ther; 2017; 24(1):e107-e108. PubMed ID: 27574930
    [No Abstract]   [Full Text] [Related]  

  • 4. Pneumatosis cystoides intestinalis as an infrequent cause of chronic abdominal pain.
    Klimova K; Pérez Valderas MD; Merino Rodríguez B; González Asanza C; Menchén Fernández-Pacheco P
    Rev Gastroenterol Mex; 2014; 79(4):302-3. PubMed ID: 25453720
    [No Abstract]   [Full Text] [Related]  

  • 5. Is nintedanib effective for idiopathic pulmonary fibrosis?
    Jeldres A; Labarca G
    Medwave; 2017 Apr; 17(Suppl2):e6918. PubMed ID: 28430774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A case of pneumatosis cystoides intestinalis secondary to sunitinib treatment for renal cell carcinoma].
    Ohtake S; Namura K; Fujikawa A; Sawada T; Ohta J; Moriyama M; Hayashi H
    Hinyokika Kiyo; 2014 Feb; 60(2):75-8. PubMed ID: 24755817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imagery of pneumatosis cystica intestinalis].
    Braham R; Said M; Rehaiem A; Jerbi Omezzine S; Memmi F; Bouabid Z; Noomene F; Golli M; Hamdi A; Gannouni A
    J Chir (Paris); 2004 May; 141(3):201-4. PubMed ID: 15249895
    [No Abstract]   [Full Text] [Related]  

  • 8. Nintedanib: A Review of Its Use in Patients with Idiopathic Pulmonary Fibrosis.
    Keating GM
    Drugs; 2015 Jul; 75(10):1131-40. PubMed ID: 26063212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nintedanib for the treatment of idiopathic pulmonary fibrosis.
    Varone F; Sgalla G; Iovene B; Bruni T; Richeldi L
    Expert Opin Pharmacother; 2018 Feb; 19(2):167-175. PubMed ID: 29327616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of the INPULSIS™ trials: two phase 3 trials of nintedanib in patients with idiopathic pulmonary fibrosis.
    Richeldi L; Cottin V; Flaherty KR; Kolb M; Inoue Y; Raghu G; Taniguchi H; Hansell DM; Nicholson AG; Le Maulf F; Stowasser S; Collard HR
    Respir Med; 2014 Jul; 108(7):1023-30. PubMed ID: 24834811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Naloxegol oxalate, pirfenidone, and nintedanib.
    Hussar DA; Jeon MM
    J Am Pharm Assoc (2003); 2015; 55(4):461-3. PubMed ID: 26161491
    [No Abstract]   [Full Text] [Related]  

  • 12. Pneumatosis cystoides intestinalis associated with sunitinib and a literature review.
    Lee YS; Han JJ; Kim SY; Maeng CH
    BMC Cancer; 2017 Nov; 17(1):732. PubMed ID: 29121860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term safety and tolerability of nintedanib in patients with idiopathic pulmonary fibrosis: results from the open-label extension study, INPULSIS-ON.
    Crestani B; Huggins JT; Kaye M; Costabel U; Glaspole I; Ogura T; Song JW; Stansen W; Quaresma M; Stowasser S; Kreuter M
    Lancet Respir Med; 2019 Jan; 7(1):60-68. PubMed ID: 30224318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffuse Pneumatosis Coli.
    Kelly GS; Grandy B; Rice J
    J Emerg Med; 2018 Jun; 54(6):e137-e139. PubMed ID: 29523422
    [No Abstract]   [Full Text] [Related]  

  • 15. Nintedanib: a novel therapeutic approach for idiopathic pulmonary fibrosis.
    Dimitroulis IA
    Respir Care; 2014 Sep; 59(9):1450-5. PubMed ID: 24782550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cetuximab-Associated Pneumatosis Intestinalis.
    Sherman E; Ramadas P; Lemke S
    Am J Ther; 2019; 26(5):e609-e610. PubMed ID: 29965806
    [No Abstract]   [Full Text] [Related]  

  • 17. Nintedanib in the management of idiopathic pulmonary fibrosis: clinical trial evidence and real-world experience.
    Rivera-Ortega P; Hayton C; Blaikley J; Leonard C; Chaudhuri N
    Ther Adv Respir Dis; 2018; 12():1753466618800618. PubMed ID: 30249169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful treatment with hyperbaric oxygen therapy for pneumatosis cystoides intestinalis as a complication of granulomatosis with polyangiitis: a case report.
    Nakatani K; Kato T; Okada S; Matsumoto R; Nishida K; Komuro H; Suganuma T
    J Med Case Rep; 2017 Sep; 11(1):263. PubMed ID: 28917259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pneumatosis Cystoides Intestinalis Secondary to Use of an α-Glucosidase Inhibitor.
    Lin WC; Wang KC
    Radiology; 2019 Mar; 290(3):619. PubMed ID: 30644816
    [No Abstract]   [Full Text] [Related]  

  • 20. Regression of pneumatosis cystoides intestinalis after discontinuing of alpha-glucosidase inhibitor administration.
    Yanaru R; Hizawa K; Nakamura S; Yoshimura R; Watanabe K; Nakamura U; Yoshinari M; Matsumoto T
    J Clin Gastroenterol; 2002 Aug; 35(2):204-5. PubMed ID: 12172373
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.